ERBB2 and breast neoplasm: As such, gaining a more thorough understanding of the biological pathways behind cancer development is a primary research goal.[37] Here, we analyze the HER2‐positive breast tumor data, a collection of seven datasets that were manually annotated by pathologists as either various healthy tissue regions, noninvasive cancer, or invasive cancer as shown in Figure 3a.